$33.42
0.310.94%
At close: -
$33.42
0.000.00%
After Hours: 4:02 PM EDT
Royalty Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $1.16 | $1.05 | 10.5 % |
Q3 | 2024-11-06 | $1.04 | $0.93 | 11.8 % |
Q2 | 2024-08-08 | $0.96 | $0.99 | -3.03 % |
Q1 | 2024-05-09 | $0.98 | $0.99 | -1.01 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $594.00M | $743.60M | -20.1 % |
Q3 | 2024-11-06 | $565.00M | $696.10M | -18.8 % |
Q2 | 2024-08-08 | $537.00M | $628.26M | -14.5 % |
Q1 | 2024-05-09 | $568.00M | $663.22M | -14.4 % |
Royalty Pharma (RPRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
The Actual EPS was $1.16, which beat the estimate of $1.05.
The Actual Revenue was $594M, which missed the estimate of $743.6M.
Browse earnings estimates, EPS, and revenue on all stocks.